 Robert Neumann
Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Daptomycin | 1 | 2012 | 19 | 0.410 |
Why?
| | Oxazolidinones | 1 | 2012 | 15 | 0.400 |
Why?
| | Acetamides | 1 | 2012 | 36 | 0.390 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2012 | 64 | 0.380 |
Why?
| | Brain Ischemia | 3 | 2023 | 321 | 0.300 |
Why?
| | Critical Illness | 3 | 2023 | 759 | 0.250 |
Why?
| | Brain Injuries | 2 | 2023 | 466 | 0.250 |
Why?
| | Hyperoxia | 2 | 2023 | 90 | 0.230 |
Why?
| | Anti-Bacterial Agents | 2 | 2018 | 1708 | 0.220 |
Why?
| | Ischemic Attack, Transient | 1 | 2023 | 60 | 0.190 |
Why?
| | Stroke | 2 | 2023 | 1072 | 0.160 |
Why?
| | Spinal Cord Vascular Diseases | 1 | 2018 | 3 | 0.160 |
Why?
| | Vasculitis, Central Nervous System | 1 | 2018 | 14 | 0.150 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2018 | 35 | 0.150 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2018 | 64 | 0.150 |
Why?
| | Intracranial Pressure | 1 | 2018 | 45 | 0.150 |
Why?
| | Brain Injuries, Traumatic | 1 | 2023 | 341 | 0.140 |
Why?
| | Respiration, Artificial | 2 | 2021 | 614 | 0.140 |
Why?
| | Vancomycin | 1 | 2018 | 78 | 0.140 |
Why?
| | Piracetam | 1 | 2017 | 13 | 0.140 |
Why?
| | Hemofiltration | 1 | 2017 | 30 | 0.140 |
Why?
| | Microbial Sensitivity Tests | 1 | 2018 | 349 | 0.130 |
Why?
| | Intracranial Hemorrhages | 1 | 2017 | 78 | 0.130 |
Why?
| | Oxygen | 1 | 2021 | 916 | 0.130 |
Why?
| | Cerebellar Diseases | 1 | 2016 | 23 | 0.130 |
Why?
| | Aneurysm, Ruptured | 1 | 2016 | 34 | 0.130 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2016 | 50 | 0.130 |
Why?
| | Intracranial Aneurysm | 1 | 2016 | 95 | 0.120 |
Why?
| | Anticonvulsants | 1 | 2017 | 208 | 0.120 |
Why?
| | Wounds and Injuries | 1 | 2021 | 711 | 0.110 |
Why?
| | Embolization, Therapeutic | 1 | 2016 | 207 | 0.110 |
Why?
| | Cerebral Ventriculitis | 1 | 2012 | 4 | 0.100 |
Why?
| | Vancomycin Resistance | 1 | 2012 | 14 | 0.100 |
Why?
| | Injections, Intraventricular | 1 | 2012 | 53 | 0.100 |
Why?
| | Linezolid | 1 | 2012 | 20 | 0.100 |
Why?
| | Enterococcus faecium | 1 | 2012 | 14 | 0.100 |
Why?
| | Endovascular Procedures | 1 | 2016 | 301 | 0.100 |
Why?
| | Radiographic Image Enhancement | 1 | 2012 | 54 | 0.100 |
Why?
| | Perfusion Imaging | 1 | 2012 | 56 | 0.100 |
Why?
| | Administration, Intravenous | 1 | 2012 | 141 | 0.100 |
Why?
| | Cerebral Angiography | 1 | 2012 | 108 | 0.100 |
Why?
| | Drainage | 1 | 2012 | 164 | 0.090 |
Why?
| | Middle Aged | 10 | 2023 | 31165 | 0.090 |
Why?
| | Hospital Communication Systems | 1 | 2010 | 6 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 1042 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2014 | 0.070 |
Why?
| | Brain | 1 | 2018 | 2677 | 0.070 |
Why?
| | Inpatients | 1 | 2010 | 477 | 0.060 |
Why?
| | Male | 9 | 2023 | 63691 | 0.060 |
Why?
| | Patient Care Team | 1 | 2010 | 601 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2023 | 10221 | 0.060 |
Why?
| | Humans | 12 | 2023 | 129687 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2510 | 0.050 |
Why?
| | Tissue Plasminogen Activator | 1 | 2023 | 222 | 0.040 |
Why?
| | Oximetry | 1 | 2021 | 88 | 0.040 |
Why?
| | Aged | 5 | 2023 | 22101 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2023 | 7064 | 0.040 |
Why?
| | Patient Outcome Assessment | 1 | 2021 | 127 | 0.040 |
Why?
| | Adult | 6 | 2023 | 35607 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2023 | 724 | 0.040 |
Why?
| | Female | 7 | 2023 | 68751 | 0.040 |
Why?
| | Decision Support Systems, Clinical | 1 | 2021 | 206 | 0.040 |
Why?
| | Thorax | 1 | 2018 | 45 | 0.040 |
Why?
| | Pressure | 1 | 2018 | 239 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2021 | 527 | 0.030 |
Why?
| | Cerebrovascular Circulation | 1 | 2018 | 228 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 766 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1594 | 0.030 |
Why?
| | Hypoxia | 1 | 2021 | 1085 | 0.030 |
Why?
| | Seizures | 1 | 2017 | 401 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2016 | 1201 | 0.030 |
Why?
| | Hemodynamics | 1 | 2018 | 1091 | 0.030 |
Why?
| | Quality Improvement | 1 | 2021 | 1108 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 713 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2012 | 114 | 0.020 |
Why?
| | Prospective Studies | 1 | 2023 | 7145 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2023 | 14525 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2010 | 233 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1433 | 0.020 |
Why?
| | Magnetics | 1 | 1987 | 43 | 0.020 |
Why?
| | Auditory Pathways | 1 | 1987 | 55 | 0.020 |
Why?
| | Program Evaluation | 1 | 2010 | 877 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 1950 | 0.010 |
Why?
| | Brain Mapping | 1 | 1987 | 575 | 0.010 |
Why?
| | Attitude of Health Personnel | 1 | 2010 | 1103 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 3772 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2010 | 1282 | 0.010 |
Why?
| | Colorado | 1 | 2010 | 4405 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6545 | 0.010 |
Why?
| | Evoked Potentials, Auditory | 1 | 1987 | 179 | 0.000 |
Why?
| | Reaction Time | 1 | 1987 | 411 | 0.000 |
Why?
| | Magnetic Resonance Imaging | 1 | 1987 | 3394 | 0.000 |
Why?
|
|
Neumann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|